Sickle Cell Disease Trial, Recruiting NCT07001189 Sponsor: Centre Hospitalier Universitaire de la Guadeloupe Condition: Sickle Cell Disease
Back to Sickle Cell Disease

Sickle Cell Disease Trial, Recruiting

NCT07001189
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 years or older
  • People who are currently experiencing a vaso-occlusive crisis (a painful episode caused by blocked blood flow, commonly associated with sickle cell disease)

Who may not be able to join:

  • Women who are pregnant or currently breastfeeding
  • People who have received a blood transfusion within the last 3 months
  • People who are not affiliated with the French social security system
  • People who have a protected legal status (such as those under guardianship or legal protection orders) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Amelie Rolle, MD, CHU de la Guadeloupe

Phone: +590590934677

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Universitaire de la Guadeloupe
Registry
ClinicalTrials.gov
Start date
5 February 2025
Est. completion
5 February 2027

Where this trial is recruiting

Guadeloupe

Primary endpoints

Inflammatory process during vaso-occlusive crises

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov